Nilotinib 150mg, 200mg Capsules
Nilotinib 150mg, 200mg capsules are used for the treatment of cancer type called chronic myelogenous leukemia. It comes under the brand name of Tasigna. The medication stops the growth of cancer cells in the user body by its active ingredients which are anti-cancer in nature.
Tasigna capsules work by inhibiting the mechanism of growth of cancer cells in the user body.it further prevents the cancer cells to multiply within the host body. The capsules here work as inhibitors.
The other drug interactions take place with such medications which lower the effectiveness of it. Interactions with azole antifungals such as itraconazole, ketoconazole, HIV viruses, macrolide antibiotics, and protease inhibitors.
1. What is Tasigna (Nilotinib) used for?
Tasigna contains nilotinib, a tyrosine kinase inhibitor used to treat Philadelphia chromosome-positive (Ph+) chronic myeloid leukemia (CML). It is indicated for newly diagnosed CML in the chronic phase and for certain patients with chronic or accelerated-phase Ph+ CML who are resistant or intolerant to previous therapy, including imatinib.
2. How does Tasigna (Nilotinib) work?
Tasigna works by inhibiting the BCR-ABL tyrosine kinase, a protein associated with the Philadelphia chromosome that promotes the growth of CML cells. By blocking this signaling pathway, nilotinib helps inhibit the proliferation of Ph+ leukemia cells. Treatment should be prescribed and monitored by a qualified healthcare professional.
3. What strengths of Tasigna capsules are available?
Tasigna capsules are available in 50 mg, 150 mg, and 200 mg strengths according to current U.S. prescribing information. Product presentations and availability can vary by market, so international buyers should confirm the required strength and packaging when making a supply enquiry.
4. How is Tasigna administered?
Tasigna is an oral capsule. For adults with newly diagnosed Ph+ CML in the chronic phase, the labeled dose is generally 300 mg twice daily; for certain adults with resistant or intolerant Ph+ CML, the recommended dose is 400 mg twice daily. Tasigna should be taken without food, with food avoided for at least 2 hours before and 1 hour after each dose. Dosage must be determined by the treating healthcare professional.
5. Can international buyers source Tasigna from Lotus International?
Lotus International supplies oncology and anticancer medicines from India for international pharmaceutical markets and accepts bulk orders. Importers, distributors, wholesalers, hospitals, and procurement organizations can contact Lotus International regarding Tasigna or nilotinib supply, including availability, quantities, packaging, documentation, and export requirements.